Office, F. E. Retraction: Dihydroartemisinin suppresses the tumorigenesis and cycle progression of colorectal cancer by targeting CDK1/CCNB1/PLK1 signaling. Frontiers Media S.A.
Chicago Style (17th ed.) CitationOffice, Frontiers Editorial. Retraction: Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling. Frontiers Media S.A.
MLA (9th ed.) CitationOffice, Frontiers Editorial. Retraction: Dihydroartemisinin Suppresses the Tumorigenesis and Cycle Progression of Colorectal Cancer by Targeting CDK1/CCNB1/PLK1 Signaling. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.